TRLFF (Maven Brands) Notes Receivable: $0.00 Mil (As of Dec. 2022)


What is Maven Brands Notes Receivable?

Maven Brands TRLFF -99.00% Notes Receivable is $0.00 Mil as of Dec. 2022.

Maven Brands's Notes Receivable for the quarter that ended in Dec. 2022 was $0.00 Mil.

Maven Brands Notes Receivable Historical Data

* Premium members only.

The historical data trend for Maven Brands's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maven Brands Notes Receivable Chart

Maven Brands Annual Data
Trend Dec14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Maven Brands Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Maven Brands Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Maven Brands (TRLFF) has a Notes Receivable of $0.00 Mil as of Dec. 2022. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Maven Brands and its competitors.
Is Maven Brands' Notes Receivable too high?
Maven Brands' current Notes Receivable is $0.00 Mil.
How does Maven Brands' Notes Receivable compare to ZTS?
Maven Brands' Notes Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Maven Brands and its competitors. Maven Brands's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maven Brands stock overvalued right now?
Maven Brands (TRLFF) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Maven Brands (TRLFF), the current Notes Receivable is $0.00 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maven Brands Business Description

Address 100 Kalamalka Lake Road, Unit 32, Vernon, BC, CAN, V1T 9G1
Maven Brands Inc is a licensed producer of medicinal cannabis for the Canadian market and has three licenses from Health Canada to cultivate, process and sell medical cannabis.